BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/19/2026 1:55:06 AM | Browse: 1 | Download: 0
 |
Received |
|
2026-03-03 10:28 |
|
Peer-Review Started |
|
2026-03-03 10:28 |
|
First Decision by Editorial Office Director |
|
2026-03-13 09:11 |
|
Return for Revision |
|
2026-03-13 09:11 |
|
Revised |
|
2026-03-25 03:53 |
|
Publication Fee Transferred |
|
2026-03-31 01:26 |
|
Second Decision by Editor |
|
2026-05-11 02:42 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-05-11 08:06 |
|
Articles in Press |
|
2026-05-11 08:06 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-05-31 14:55 |
|
Publish the Manuscript Online |
|
2026-08-19 01:55 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Prognostic value of systemic immune-inflammation index in patients with gastric cancer treated with immune checkpoint inhibitors
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Rui Guo and Meng Gao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Rui Guo, Department of Laboratory Medicine, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, No. 7 Weiwu Road, Jinshui District, Zhengzhou 462000, Henan Province, China. guorui2460@163.com |
| Key Words |
Systemic immune-inflammation index; Gastric cancer; Immune checkpoint inhibitors; Prognosis; Biomarkers; Retrospective studies |
| Core Tip |
The systemic immune-inflammation index (SII), calculated from routine blood counts, integrates neutrophils, lymphocytes, and platelets to reflect the host immune-inflammatory balance. This retrospective study of 238 advanced gastric cancer patients treated with immune checkpoint inhibitors demonstrates that a high baseline SII (≥ 593.995) independently predicts poor progression-free survival and lower disease control rates. Combining SII with clinical parameters significantly improves predictive accuracy for early progressive disease, suggesting SII as a practical and accessible biomarker for risk stratification in immune checkpoint inhibitors-treated gastric cancer. |
| Publish Date |
2026-08-19 01:55 |
| Citation |
Guo R, Gao M. Prognostic value of systemic immune-inflammation index in patients with gastric cancer treated with immune checkpoint inhibitors. World J Gastroenterol 2026; 32(34): 119567
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i34/119567.htm |
| DOI |
https://doi.org/10.3748/wjg.v32.i34.119567 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
